Related Experiment Videos
Endogenous bradykinin activity in Dahl rats
Journal of Cardiovascular Pharmacology
|January 1, 1993
Summary
Endogenous bradykinin (BK) lowers blood pressure in salt-sensitive rats on low-salt diets, but this effect is lost on high-salt diets. This suggests BK plays a role in regulating blood pressure influenced by salt intake.
Area of Science:
- Cardiovascular Physiology
- Renal Physiology
- Pharmacology
Background:
- Endogenous bradykinin (BK) is implicated in blood pressure (BP) regulation.
- Dahl-sensitive (DS) and Dahl-resistant (DR) rats are models for salt-sensitive and salt-resistant hypertension, respectively.
- Dietary salt (NaCl) intake significantly impacts BP in these rat models.
Purpose of the Study:
- To investigate the role of endogenous bradykinin (BK) in basal blood pressure (BP) regulation in DS and DR rats under varying NaCl diets.
- To determine how high-salt (H) versus low-salt (L) diets affect BK's influence on BP in these rat models.
Main Methods:
- Four groups of rats were studied: DSH (high salt), DSL (low salt), DRH (high salt), DRL (low salt).
- Endogenous BK activity was assessed using a specific BK antagonist (B4146) infused intraarterially.
- Sensitivity to exogenous BK was evaluated via intraarterial injections after antagonist infusion.
Main Results:
- Dahl-sensitive rats on a high-salt diet (DSH) exhibited significantly higher basal mean BP (MBP) compared to other groups.
- BK antagonist infusion increased MBP in DSL rats, indicating a vasodepressor effect of BK.
- The vasodepressor effect of endogenous BK was significantly reduced in DS rats fed a high-salt diet compared to those on a low-salt diet.
Conclusions:
- Endogenous bradykinin (BK) exerts a vasodepressor effect in Dahl-sensitive rats, particularly when consuming a low-salt diet.
- A high-salt diet suppresses the vasodepressor activity of endogenous BK in Dahl-sensitive rats.
- These findings highlight the interplay between dietary salt, endogenous BK, and blood pressure regulation in salt-sensitive hypertension.